Published in J Clin Pathol on November 01, 1996
Sotos syndrome, infantile hypercalcemia, and nephrocalcinosis: a contiguous gene syndrome. Pediatr Nephrol (2011) 0.88
Bone disease in primary hypercalciuria. Clin Cases Miner Bone Metab (2008) 0.83
Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones. Clin J Am Soc Nephrol (2015) 0.82
Phosphaturia as a promising predictor of recurrent stone formation in patients with urolithiasis. Korean J Urol (2010) 0.81
Vascular Calcification and Stone Disease: A New Look towards the Mechanism. J Cardiovasc Dev Dis (2015) 0.80
Biochemical diagnosis in 3040 kidney stone formers in Argentina. Urolithiasis (2015) 0.79
Problems in the metabolic evaluation of renal stone disease: audit of intra-individual variation in urine metabolites. Urol Res (2006) 0.77
Renal phosphate leak in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urol Res (2003) 0.76
Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study. J Clin Pathol (2001) 0.75
A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med (1993) 5.87
The pathogenesis and treatment of kidney stones. N Engl J Med (1992) 5.32
Nomogram for derivation of renal threshold phosphate concentration. Lancet (1975) 3.20
Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med (1994) 3.16
Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int (1979) 2.79
Vitamin D. Lancet (1995) 2.45
Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci (1989) 2.07
The frequency of urolithiasis in hospital discharge diagnoses in the United States. Invest Urol (1978) 1.68
Tumor-induced osteomalacia--unveiling a new hormone. N Engl J Med (1994) 1.61
Epidemiology of urolithiasis in Japan: a chronological and geographical study. Urol Int (1990) 1.59
Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans. J Clin Invest (1986) 1.41
Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ (1995) 1.41
Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest (1973) 1.39
Renal calculi and self-medication with multivitamin preparations containing vitamin D. Clin Sci (1972) 1.14
Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat. Biochem Biophys Res Commun (1991) 1.01
Urolithiasis. A study of its frequency. Scand J Urol Nephrol (1976) 0.97
Possible link between vitamin D and hyperoxaluria in patients with renal stone disease. Clin Sci (Lond) (1993) 0.93
Short- and long-term biological variation in analytes in urine of apparently healthy individuals. Clin Chem (1981) 0.87
Physiological basis for absorptive and renal hypercalciurias. Am J Physiol (1979) 0.85
The role of calcium intake in preventing bone fragility, hypertension, and certain cancers. J Nutr (1994) 0.84
Calcium oxalate nephrolithiasis: defective oxalate transport. Kidney Int (1991) 0.80
ADSA Foundation Lecture. Low calcium intake: the culprit in many chronic diseases. J Dairy Sci (1994) 0.79
Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol (2001) 1.76
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69
Measurement of height in the elderly. J Am Geriatr Soc (1990) 1.64
Differences in rates of glycation (glycation index) may significantly affect individual HbA1c results in type 1 diabetes. Ann Clin Biochem (1999) 1.60
The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. Q J Med (1982) 1.49
Unrecognized basilic vein variation leading to complication during basilic vein transposition arteriovenous fistula creation: case report and implications for access planning. Eur J Vasc Endovasc Surg (2010) 1.49
14C triolein breath test: a routine test in the gastroenterology clinic? Gut (1986) 1.48
CNS depression from intrathecal morphine. Anesthesiology (1980) 1.47
Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43. Am J Hum Genet (2001) 1.42
Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) (1980) 1.41
Reduction of vein graft intimal hyperplasia by ex vivo treatment with desferrioxamine manganese. J Vasc Res (1993) 1.41
Multivariate analysis of glycosylated haemoglobin in insulin-treated diabetics. J R Soc Med (1985) 1.39
Allergic contact dermatitis from medium-chain triglycerides in a moisturizing lotion. Contact Dermatitis (2002) 1.38
Sensitivity of yeasts to 5-fluorocytosine. J Med Microbiol (1973) 1.35
Epidermal metabolism in heredopathia atactica polyneuritiformis (Refsum's disease). J Invest Dermatol (1978) 1.34
Mortality in acute pancreatitis. Ann R Coll Surg Engl (1984) 1.33
Sweet's syndrome: an unusual cutaneous feature of Crohn's disease or ulcerative colitis. The South West Gastroenterology Group. Eur J Gastroenterol Hepatol (1997) 1.25
Dermatitis herpetiformis--a skin manifestation of a generalized disturbance in immunity. Q J Med (1978) 1.24
Pseudohypercalcaemia in two patients with IgM paraproteinaemia. Ann Clin Biochem (1997) 1.20
Value of emergency cardiac enzymes: audit in a coronary care unit. J R Soc Med (1991) 1.17
Airway surface pH in subjects with cystic fibrosis. Eur Respir J (2003) 1.15
Prolactin studies in "functionless" pituitary tumours. Br Med J (1975) 1.07
Is there a relationship between lupus erythematosus and lichen planus? Br J Dermatol (1977) 1.07
Respiratory depression after intrathecal narcotics. Anaesthesia (1980) 1.06
Dysthyroid eye disease with radiological features of orbital tumour. J R Soc Med (1992) 1.05
Simultaneous systemic lupus erythematosus and dermatitis herpetiformis. Arch Dermatol (1976) 1.04
A novel five-microlitre capillary system for home glucose monitoring. Ann Clin Biochem (1981) 1.03
Epidermal abnormalities in Refsum's disease. Br J Dermatol (1977) 1.03
Systemic toxicity from topically applied salicylic acid. Br Med J (1979) 1.00
Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy. Acta Endocrinol (Copenh) (1976) 0.99
The abnormal dermis in pyogenic granuloma. Histochemical and ultrastructural observations. J Am Acad Dermatol (1980) 0.97
Heat shock protein studies in type 1 and type 2 diabetes and human islet cell culture. Diabet Med (1995) 0.97
Pregnancy, prolactin, and pituitary tumours. Br Med J (1975) 0.93
Posterior uterine rupture causing fetal expulsion into the abdominal cavity: a rare case of neonatal survival. Case Rep Obstet Gynecol (2011) 0.93
Generalised allergic reaction with synthetic human insulin. Lancet (1982) 0.92
The efficacy of histamine antagonists as antipruritics in experimentally induced pruritus. Arch Dermatol Res (1979) 0.89
An investigation of hydrolytic techniques for the amino acid analysis of foodstuffs. J Sci Food Agric (1973) 0.88
Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts. Eur J Vasc Endovasc Surg (1998) 0.88
Computational study of haemodynamic effects of entry- and exit-tear coverage in a DeBakey type III aortic dissection: technical report. Eur J Vasc Endovasc Surg (2011) 0.88
Measurement of nucleic acid concentrations using the DyNA Quant and the GeneQuant. Biotechniques (1997) 0.87
Alterations in wall tension and shear stress modulate tyrosine kinase signaling and wall remodeling in experimental vein grafts. J Vasc Surg (1999) 0.86
Body weight estimation of elderly patients by nomogram. J Am Geriatr Soc (1994) 0.85
Pemphigus in a patient treated with penicillamine for generalized morphea. Arch Dermatol (1976) 0.85
Factors associated with Colles' fracture in the elderly. Gerontology (1991) 0.85
Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function. J Surg Res (1993) 0.85
Cushing's syndrome, nodular adrenal hyperplasia and virilizing carcinoma. Clin Endocrinol (Oxf) (1978) 0.84
Primary pneumococcal peritonitis--a brief report. Ir J Med Sci (1989) 0.84
Alopecia areata arising in patients receiving cyclosporin immunosuppression. Br J Dermatol (1995) 0.84
Adrenal steroidogenesis in hirsute women. Clin Endocrinol (Oxf) (1980) 0.83
Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction. J Urol (1994) 0.83
Wegener's granulomatosis presenting as granulomatous prostatitis causing urinary retention. Br J Urol (1990) 0.82
Pyoderma gangrenosum: successful treatment with minocycline. Clin Exp Dermatol (1981) 0.82
Modulation of tissue factor protein expression in experimental venous bypass grafts. Arterioscler Thromb Vasc Biol (1997) 0.82
Histamine receptors in human skin: indirect evidence. Br J Dermatol (1982) 0.82
Postoperative reduction of high serum cholesterol concentrations and experimental vein bypass grafts. Effect on the development of intimal hyperplasia and abnormal vasomotor function. J Thorac Cardiovasc Surg (1994) 0.82
Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts. J Vasc Surg (1997) 0.82
Locally applied antisense oligonucleotide to proliferating cell nuclear antigen inhibits intimal thickening in experimental vein grafts. Ann Vasc Surg (1998) 0.81
Long-term human vein graft contractility and morphology: a functional and histopathological study of retrieved coronary vein grafts. Br J Surg (1994) 0.81
Reduction in wound morbidity rates following endoscopic saphenous vein harvest. Ann Vasc Surg (2001) 0.81
The fatty acid composition of skin and plasma lipids in Refsum's disease. Clin Chim Acta (1978) 0.81
Sensory responses of human skin to synthetic histamine analogues and histamine. Br J Clin Pharmacol (1980) 0.81
Evolution of the lesion of discoid lupus erythematosus: a comparison with lichen planus. Br J Dermatol (1977) 0.81
Recurrent tenosynovitis in Sweet's syndrome. Rheumatology (Oxford) (2002) 0.80
Pervanadate inhibits mitogen-activated protein kinase kinase-1 in a p38MAPK-dependent manner. FEBS Lett (1998) 0.80
Lack of effect of carbon monoxide inhibitor on relaxation induced by electrical field stimulation in corpus cavernosum. Urol Res (1994) 0.80
The use of etomidate infusions during anaesthesia for cardiopulmonary bypass. Anaesthesia (1983) 0.80
Erythema gyratum repens--an immunologically mediated dermatosis? Br J Dermatol (1977) 0.80
Pemphigus foliaceus: an adverse reaction to lisinopril. J Dermatolog Treat (2004) 0.80
Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts. J Vasc Surg (2001) 0.79
Heterogeneity in adrenal steroidogenesis in normal men and women. Clin Endocrinol (Oxf) (1979) 0.79
Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia. J Surg Res (1997) 0.79
The effect of oral folic acid on glutathione, glycaemia and lipids in Type 2 diabetes. Diabetes Nutr Metab (2004) 0.79
Adenoviral-mediated inhibition of G beta gamma signaling limits the hyperplastic response in experimental vein grafts. Surgery (1998) 0.79
Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts. J Surg Res (1998) 0.78
External support modulates G protein expression and receptor coupling in experimental vein grafts. Surgery (1999) 0.78
Troponin I, laboratory issues, and clinical outcomes in a district general hospital: crossover study with "traditional" markers of myocardial infarction in a total of 1990 patients. J Clin Pathol (2004) 0.78
An audit of cardiac pacing in the elderly: effect of myocardial infarction on outcome. J Am Geriatr Soc (1993) 0.78
Alterations in collagen subtype III and IV protein in experimental venous bypass grafting. Coron Artery Dis (1998) 0.78
Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809. Surgery (1998) 0.78
Modulation of vasoactive intestinal polypeptide (VIP)-mediated relaxation by nitric oxide and prostanoids in the rabbit corpus cavernosum. J Urol (1995) 0.78
Euglycaemic diabetic ketoacidosis. Hosp Med (2003) 0.78
Sonographic findings of testicular prosthesis rupture. Clin Radiol (2011) 0.78
Percutaneous transluminal revascularization for renal artery stenosis: Veterans Affairs Puget Sound Health Care System experience. J Vasc Surg (2001) 0.78
Lichen sclerosus arising from a chronic wound and coexistent with multiple sclerosis. J Eur Acad Dermatol Venereol (2005) 0.78
Electrical stimulation therapy in the treatment of cigarette smoking. J Subst Abuse (1998) 0.77
Carbamazepine-induced pemphigus. Clin Exp Dermatol (2003) 0.77
Generalized morphoea in a patient with Felty's syndrome. J Eur Acad Dermatol Venereol (2000) 0.77
Acute photosensitivity from the sunscreen 2-ethoxyethyl-p-methoxycinnamate. Contact Dermatitis (1982) 0.77
Reduction of experimental vein graft intimal hyperplasia by ketanserin. J Surg Res (1993) 0.77
Analgesic action of extradural fentanyl. Br J Anaesth (1980) 0.76
The effect of thyroxine on small intestinal motility in the elderly. Clin Endocrinol (Oxf) (1991) 0.76
Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts. J Surg Res (1998) 0.76
Rothmund-Thomson syndrome and malignant disease. Clin Exp Dermatol (1982) 0.76
Ectopic acromegaly. Postgrad Med J (1997) 0.76
Effects of methylglyoxal on central and peripheral cholinergic responses. Arch Toxicol Suppl (1986) 0.76
Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts. J Surg Res (1999) 0.76